发明名称 Methods for reducing the incidence of necrotizing enterocolitis
摘要 Enteral formulas that contain long-chain polyunsaturated fatty acids (PUFAs), as arachidonic acid (AA) and docosahexaenoic acid (DHA) that are essentially free of cholesterol, are described. More particularly, the invention relates to methods for reducing the incidence of necrotizing enterocolitis by administering compositions which provide omega -6 and omega -3 long chain PUFAs, phospholipids and/or choline. Compositions from egg yolk lipids are presently preferred as they contain omega -6 and omega -3 long chain PUFAs and are predominantly in a phosphtidylcholine form. This is believed to provide a synergistic effect.
申请公布号 US6080787(A) 申请公布日期 2000.06.27
申请号 US19970943576 申请日期 1997.10.03
申请人 ABBOTT LABORATORIES 发明人 CARLSON, SUSAN E.;PONDER, DEBRA L.;MONTALTO, MICHAEL B.;DOHNALEK, MARGARET H.;BENSON, JOHN D.;BORROR, DAVID A.;DIODATO, DAVID V.
分类号 A61K31/202;(IPC1-7):A61K31/202;A61K31/225;A61K31/685 主分类号 A61K31/202
代理机构 代理人
主权项
地址